Registration for a live webinar on 'Phasing Out Animal Testing: A New Era for Pharmaceutical Innovation' is now open.
See webinar details
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Luminal Gastroenterology
-
31 min
1. Novel treatments for GI malignancies- Prof. Bert H. O'Neil
-
40 min
2. The spectrum of GERD implications for assessment and management- Prof. Eamonn M. M. Quigley
-
54 min
3. Oro-pharyngeal and esophageal motility and dysmotility- Dr. John E. Pandolfino
-
55 min
4. Eosinophilic esophagitis and other non-reflux esophageal disorders- Prof. David Katzka
-
39 min
-
17 min
-
48 min
-
48 min
8. Gastric cancer, gastritis and the role of H. pylori- Prof. Anthony Axon
-
48 min
9. Celiac disease- Prof. Ciaran Kelly
-
43 min
10. IBD for the non-gastroenterologist- Prof. Sunanda Kane
-
34 min
11. The enteric microbiota in health and disease- Dr. Francisco Guarner
-
45 min
12. Colorectal cancer and hereditary colon cancer syndromes- Prof. Carol A. Burke
-
39 min
13. The spectrum of GI ischemia 1- Prof. Lawrence J. Brandt
-
31 min
14. The spectrum of Gl ischemia 2- Prof. Lawrence J. Brandt
-
41 min
15. Constipation and defecation disorders- Prof. Satish S. C. Rao
-
40 min
16. Diverticular disease of the colon- Dr. Dale Vimalachandran
-
73 min
17. Irritable bowel syndrome (IBS)- Prof. Eamonn M. M. Quigley
-
27 min
18. Evidence-based management of non-variceal upper GI bleeding- Prof. Joseph J. Sung
- Hepatology
-
32 min
19. Hepatitis B virus (HBV)- Prof. Marco Olivera-Martinez
-
26 min
20. Hepatitis C - cure of infection- Prof. Mark Mailliard
-
46 min
21. Drug-induced liver injury: importance, epidemiology, and mechanisms of DILI- Prof. James H. Lewis
-
26 min
22. Drug-induced liver injury: risk factors and drug development in DILI- Prof. James H. Lewis
-
39 min
23. Drug-induced liver injury: HDS, diagnosing, treating and preventing DILI- Prof. James H. Lewis
-
22 min
24. Portal hypertension- Prof. John Reinus
-
55 min
25. Portal hypertension: at the bedside- Dr. Clara Y. Tow
-
29 min
26. The management of chronic liver disease, including transplantation 1- Prof. Timothy M. McCashland
-
21 min
27. The management of chronic liver disease, including transplantation 2- Prof. Timothy M. McCashland
-
34 min
28. Hereditary hemochromatosis: what have we learnt from population studies- Prof. John K. Olynyk
-
38 min
29. Immune-mediated liver disease- Dr. Jenny Heathcote
-
51 min
30. Alcoholic liver disease- Prof. Michael Lucey
- The Pancreas and Biliary Tree
-
46 min
31. Acute pancreatitis- Prof. Davor Štimac
-
49 min
32. Chronic pancreatitis- Prof. Christopher Forsmark
-
47 min
33. Pancreatic cancer- Prof. Randall Brand
-
20 min
- Archived Lectures *These may not cover the latest advances in the field
-
52 min
35. The management of other aspects of chronic liver disease, including transplantation- Prof. Timothy M. McCashland
-
38 min
36. Chronic viral hepatitis B and C- Prof. Mark Mailliard
-
41 min
37. Pancreatic cancer- Prof. Randall Brand
-
72 min
38. Acute viral hepatitis- Prof. Geoffrey Dusheiko
-
33 min
39. Diverticular disease- Dr. Charles Knowles
-
57 min
40. The spectrum of gastrointestinal ischemia: 2010- Prof. Lawrence J. Brandt
-
51 min
41. Acute pancreatitis- Prof. Davor Štimac
Printable Handouts
Navigable Slide Index
- Introduction
- Issues in GERD
- Definition of GERD
- Los Angeles classification
- Get your definitions right
- NERD is important
- Prevalence of GERD (1)
- Prevalence of GERD (2)
- Symptom relief after 4 weeks in NERD patients
- Predictors of NERD vs. ERD
- NERD is not homogenous
- 24-hr pH study
- Is most NERD MERD?
- Mechanisms of symptom production in NERD
- Sub classification of NERD
- Functional heartburn (1)
- Predictors of functional heartburn vs. pH + NERD
- Development of symptoms in GERD patients
- Laparoscopic fundoplication
- Functional heartburn (2)
- Role of DGER in "resistant" GERD
- NERD: management issues
- What are the limits of GERD?
- Heartburn and quality of life (1)
- Heartburn and quality of life (2)
- GERD in China (1)
- GERD in China (2)
- Symptom severity and quality of life
- Natural history
- Progression in ProGERD (1)
- Progression in ProGERD (2)
- Determination of GERD
- Extra-esophageal, supra-esophageal GERD
- Laryngitis
- Non-acid reflux
- Cough and GERD
- Meta-analysis of primary outcome
- Meta-analysis of cough scores
- Cochrane
- Non-traditional reflux and cough
- Asthma
- PPI and asthma (1)
- PPI and asthma (2)
- Scleroderma and GERD
- The Barrett's dilemma
- How do we proceed?
- Risk factors for Barrett's and adenocarcinoma
- Can we predict progression?
- Genetics
- Screen followed by surveillance?
- Prague criteria
- Barrett's management issues
- GERD management issues
- Summary - approaches to the patients with GERD
- Issues in choosing a PPI
- Key points
Topics Covered
- What is GERD
- NERD non-erosive reflux disease
- Predictors of NERD vs. ERD
- Mechanisms of symptom production in NERD
- Functional heartburn
- Predictors of functional heartburn vs. pH + NERD
- Factors leading to the development of symptoms in GERD patients
- Role of DGER in "resistant" GERD
- NERD: management issues
- The limits of GERD
- Progression in ProGERD
- Extra-esophageal, supra-esophageal GERD
- Laryngitis
- Cough and GERD
- Asthma and GERD
- Scleroderma and GERD
- The Barrett's dilemma
- Risk factors for Barrett's and adenocarcinoma
- Genetic markers that can predict progression
- Barrett's management issues
- GERD management issues
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Quigley, E.M.M. (2011, February 15). The spectrum of GERD implications for assessment and management [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved March 28, 2025, from https://doi.org/10.69645/ABUY2588.Export Citation (RIS)
Publication History
- Published on February 15, 2011
Financial Disclosures
- Prof. Eamonn M. M. Quigley, Consultant: Alimentary Health, Allergen, Commonwealth Laboratories, Rhythm, Salix, Synergy, Vibrant Speaker’s Bureau: Procter and Gamble Grant/Research Support (Principal Investigator): Rhythm, Therevance, Vibrant Stock Shareholder (Self-managed): Alimentary Health
The spectrum of GERD implications for assessment and management
Published on February 15, 2011
40 min
